Incidental findings from cell-free fetal DNA-based non-invasive prenatal testing: Research progress on maternal tumors.
10.3760/cma.j.cn511374-20251217-00727
- Author:
Zhuangping ZHANG
1
,
2
;
Xinni SHU
;
Yaping HOU
Author Information
1. Medical Genetics Center, Guangdong Provincial Maternal and Child Health Care Hospital, Guangzhou, Guangdong 511442, China. hwyp26@
2. com.
- Publication Type:English Abstract
- MeSH:
Humans;
Female;
Pregnancy;
Cell-Free Nucleic Acids/blood*;
Prenatal Diagnosis/methods*;
Incidental Findings;
Neoplasms/genetics*;
Noninvasive Prenatal Testing/methods*;
Aneuploidy;
Fetus/metabolism*
- From:
Chinese Journal of Medical Genetics
2026;43(4):301-306
- CountryChina
- Language:Chinese
-
Abstract:
Non-invasive prenatal testing (NIPT) based on fetal free DNA is a non-invasive technique to screen for common fetal aneuploidies by analyzing cell-free fetal DNA (cffDNA) in the peripheral blood of pregnant women. This technique has opened a new era of prenatal screening for its high safety and reliability. In recent years, it has been shown that NIPT can not only screen for fetal aneuploidies, but may also reveal maternal genomic abnormalities. The incidental detection of maternal tumors has aroused widespread concern in the clinical settings. The aim of this review is to systematically summarize the research progress of NIPT technique in incidental detection of maternal tumors, and to discuss its clinical significance, technical challenges, and future development direction. It has been found that multiple chromosome aneuploidies (MCAs) in NIPT detection is one of the important biomarkers suggesting occult maternal malignant tumors. In this paper, the relevant progress of NIPT technique in the incidental discovery of maternal tumors were reviewed in order to provide a reference for individualized and standardized application of NIPT technique in maternal health monitoring.
